Showing results (131-140 of 144) with videos related to

Sort By:
Pageof 15
American Journal of Hypertension|December 7, 2019
Factors Associated With Treatment and Control of Hypertension in a Healthy Elderly Population Free of Cardiovascular Disease: A Cross-sectional StudyEnayet K Chowdhury, Mark R Nelson, Michael E Ernst, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|March 23, 2017
Baseline Characteristics of Participants in the ASPREE (ASPirin in Reducing Events in the Elderly) StudyJohn J McNeil, Robyn L Woods, Mark R Nelson, et al.
The New England Journal of Medicine|September 18, 2018
Effect of Aspirin on Disability-free Survival in the Healthy ElderlyJohn J McNeil, Robyn L Woods, Mark R Nelson, et al.
The New England Journal of Medicine|September 18, 2018
Effect of Aspirin on All-Cause Mortality in the Healthy ElderlyJohn J McNeil, Mark R Nelson, Robyn L Woods, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 2, 2020
Medically actionable pathogenic variants in a population of 13,131 healthy elderly individualsPaul Lacaze, Robert Sebra, Moeen Riaz, et al.
European Heart Journal|August 12, 2025
Aspirin, cardiovascular events, and major bleeding in older adults: extended follow-up of the ASPREE trialRory Wolfe, Jonathan C Broder, Zhen Zhou, et al.
The New England Journal of Medicine|September 18, 2018
Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy ElderlyJohn J McNeil, Rory Wolfe, Robyn L Woods, et al.
Stroke|September 21, 2020
Rivaroxaban for Prevention of Covert Brain Infarcts and Cognitive Decline: The COMPASS MRI SubstudyMukul Sharma, Robert G Hart, Eric E Smith, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|July 31, 2018
Rationale, design, and baseline participant characteristics in the MRI and cognitive substudy of the cardiovascular outcomes for people using anticoagulation strategies trialMukul Sharma, Robert G Hart, Eric E Smith, et al.
Gastroenterology|June 2, 2019
Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or AspirinPaul Moayyedi, John W Eikelboom, Jackie Bosch, et al.
Pageof 15